![InnoPharma Logo](/news-release/logo/245643/0/245643.jpg?lastModified=12%2F10%2F2016%2007%3A16%3A30&size=2)
InnoPharma Inc. Completes $20 Million Term Loan Facility
November 13, 2013 08:00 ET
|
InnoPharma, Inc
PISCATAWAY, NJ, Nov. 13, 2013 (GLOBE NEWSWIRE) -- InnoPharma, Inc. today
announced that it has closed on a $20 million term loan facility,
provided by Athyrium Capital Management through its...
![InnoPharma Logo](/news-release/logo/245643/0/245643.jpg?lastModified=12%2F10%2F2016%2007%3A16%3A30&size=2)
InnoPharma Inc. Appoints Vish Shetty as Vice President, Business Development & Alliance Management
November 11, 2013 08:00 ET
|
InnoPharma, Inc
PISCATAWAY, NJ, Nov. 11, 2013 (GLOBE NEWSWIRE) -- InnoPharma, Inc.
today announced the appointment of Vish Shetty to the role of vice
president, business development & alliance management.
Mr....
![InnoPharma Logo](/news-release/logo/245643/0/245643.jpg?lastModified=12%2F10%2F2016%2007%3A16%3A30&size=2)
InnoPharma Inc. Announces Commercial Launch of Acamprosate Delayed-Release Tablets in the United States
August 15, 2013 08:00 ET
|
InnoPharma, Inc
PISCATAWAY, NJ, Aug. 15, 2013 (GLOBE NEWSWIRE) -- InnoPharma, Inc.
today announced the launch of acamprosate calcium, 333 mg
delayed-release tablets (generic equivalent of
Campral®). ...
![InnoPharma Logo](/news-release/logo/245643/0/245643.jpg?lastModified=12%2F10%2F2016%2007%3A16%3A30&size=2)
InnoPharma Inc. Announces Launch of Cosyntropin Injection, 0.25mg/vial in the United States
April 08, 2013 08:00 ET
|
InnoPharma, Inc
PISCATAWAY, N.J., April 8, 2013 (GLOBE NEWSWIRE) -- InnoPharma, Inc.
today announced the commercial launch of cosyntropin injection,
0.25mg/vial (generic equivalent of Cortrosyn®) in...
![InnoPharma Logo](/news-release/logo/245643/0/245643.jpg?lastModified=12%2F10%2F2016%2007%3A16%3A30&size=2)
InnoPharma Inc. Announces Launch of Generic Cidofovir Injection in the United States
March 08, 2013 08:00 ET
|
InnoPharma, Inc
PISCATAWAY, NJ, March 8, 2013 (GLOBE NEWSWIRE) -- InnoPharma, Inc.
today announced the launch of cidofovir injection (generic
equivalent of Vistide®) in 5mL single-use vials. ...